UK-based AI-first drug design and development company
Isomorphic Labs has raised €2.3B across 2 funding rounds from 6 investors, most recently a Series B round in May 2026. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-13 | Series B | €1.8B | Alphabet,CapitalG,GV,Temasek,Thrive Capital,UK Sovereign AI Fund | View deal → |
| 2025-03-31 | Other | €555M | Alphabet,GV,Thrive Capital | View deal → |
AI-generated analysis · every figure traces to cited rounds.
